Essential Partners’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.86K Sell
138
-85
-38% -$2K ﹤0.01% 1814
2026
Q1
$5.07K Buy
223
+222
+22,200% +$5.25K ﹤0.01% 1568
2025
Q4
$27 Buy
+1
New +$30 ﹤0.01% 2694
2025
Q3
– Sell
-75
Closed -$2.35K – 2706
2025
Q2
$2.35K Buy
+75
New +$2.48K ﹤0.01% 1268

Other funds holding ENOV

Essential Partners's ENOV Position: Q2 2026 in Review

Essential Partners reduced its Enovis (ENOV) stake by 38% in Q2 2026, selling an estimated $2K and leaving 138 shares worth $2.86K. The position accounts for ﹤0.01% of the portfolio, ranked #1814.

Essential Partners first reported a position in ENOV in Q2 2025 and has held it in 4 quarters since. The position peaked at $5.07K in Q1 2026. 253 funds tracked by Wall St. Rank hold ENOV as of Q2 2026.

  • Essential Partners held 138 shares of Enovis worth $2.86K as of Q2 2026.
  • Essential Partners sold 85 Enovis shares in Q2 2026, an estimated $2K.
  • Enovis made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #1814 holding.
  • Essential Partners first reported a position in Enovis in Q2 2025 and has held it in 4 quarters since.
  • Essential Partners's Enovis position peaked at $5.07K in Q1 2026.
  • 253 funds tracked by Wall St. Rank held Enovis as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.